Veraxa Biotech is trading 6.1% higher at $1.04 on October 29, 2026, with its catalyst still uncertain. - No new company-specific announcement or reliable report identifying a catalyst surfaced in the search. The latest company releases found were dated October 13 and October 7. - The broader market is lower, so the gain does not appear to track the market’s direction. No directly supported explanation for the rise has emerged.